A variant in IL6ST with a selective IL-11 signaling defect in human and mouse

  • Tobias Schwerd (Geteilte/r Erstautor/in)
  • Freia Krause (Geteilte/r Erstautor/in)
  • Stephen R F Twigg (Geteilte/r Erstautor/in)
  • Dominik Aschenbrenner
  • Yin-Huai Chen
  • Uwe Borgmeyer
  • Miryam Müller
  • Santiago Manrique
  • Neele Schumacher
  • Steven A Wall
  • Jonathan Jung
  • Timo Damm
  • Claus-Christian Glüer
  • Jürgen Scheller
  • Stefan Rose-John
  • E Yvonne Jones
  • Arian Laurence
  • Andrew O M Wilkie (Geteilte/r Letztautor/in)
  • Dirk Schmidt-Arras (Geteilte/r Letztautor/in)
  • Holm H Uhlig (Geteilte/r Letztautor/in)

Abstract

The GP130 cytokine receptor subunit encoded by IL6ST is the shared receptor for ten cytokines of the IL-6 family. We describe a homozygous non-synonymous variant in IL6ST (p.R281Q) in a patient with craniosynostosis and retained deciduous teeth. We characterize the impact of the variant on cytokine signaling in vitro using transfected cell lines as well as primary patient-derived cells and support these findings using a mouse model with the corresponding genome-edited variant Il6st p.R279Q. We show that human GP130 p.R281Q is associated with selective loss of IL-11 signaling without affecting IL-6, IL-27, OSM, LIF, CT1, CLC, and CNTF signaling. In mice Il6st p.R279Q lowers litter size and causes facial synostosis and teeth abnormalities. The effect on IL-11 signaling caused by the GP130 variant shows incomplete penetrance but phenocopies aspects of IL11RA deficiency in humans and mice. Our data show that a genetic variant in a pleiotropic cytokine receptor can have remarkably selective defects.

Bibliografische Daten

OriginalspracheEnglisch
ISSN2095-4700
DOIs
StatusVeröffentlicht - 11.06.2020
PubMed 32566365